All news updates:

Nov 14, 2024 |
FDA clearance for icobrain aria
FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment
Sep 10, 2024 |
DISQOVER 7: The next generation knowledge discovery platform
ONTOFORCE, a leader in semantic technology for life sciences, announces the launch of DISQOVER 7, the most advanced version of its knowledge discovery platform.
Aug 20, 2024 |
Thirona's retina business unit acquired by Revenio Group
Thirona to continue focus on pulmonary diseases and expanding within the interventional pulmonology space, while its RetCAD™ division will continue its impact by joining forces with a global leader in eye care solutions.
Jun 20, 2024 |
LynxCare appoints Jeanne Kehren to new CEO
With Jeanne Kehren, LynxCare brings onboard a profound expertise in innovative healthcare data solutions and experience in accelerating pharmaceutical innovation through technology.
Feb 16, 2024 | Katleen Vandersmissen
Laurens de Vries joins HERAN Partners as Analyst
Laurens de Vries supports the HERAN team in focussing on investment opportunities and mapping market segments, in order to actively source innovative ventures.
Sep 19, 2023 | Katleen Vandersmissen
13th Investment for HERAN Partners: Broken String Biosciences (UK)
HERAN Partners invests in Broken String Biosciences: a genomics company building a technology platform to drive the development of cell and gene therapies.
Sep 14, 2023 | Katleen Vandersmissen
Thirona secures EUR 7,5m via investment round and EIC grant
Thirona raises EUR 7,5m in new financing round to accelerate the adoption of its breakthrough innovations for precision medicine
Sep 05, 2023 | Katleen Vandersmissen
FOx BIOSYSTEMS appoints Dr. Mark Truesdale as CEO
New CEO Mark Truesdale will bring the disruptive technology of FOx Biosystems to a wider audience and ensure its further success
Jun 01, 2023 | Katleen Vandersmissen
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
HERAN Partners co-leads the GBP 6,5M financing round of Hypervision Surgical: a London-based venture building an advanced surgical imaging and data analytics platform.

Join a Heran Fund

We are open to novel investments and are always planning the next funds and investment strategies. Leave your details below and our partners will be in touch.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Pitch your company

Submit your pitch below. We receive dozens of pitches each week and process these dilligently. We might not be able to get back to you immediately.

Max file size 10MB.
Uploading...
fileuploaded.jpg
Upload failed. Max size for files is 10 MB.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.